PARP inhibitors: its role in treatment of cancer
Chinese Journal of Cancer · 05.07.2011 · 463-471
DOI: 10.5732/cjc.011.10111 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chinese Journal of Cancer, erschienen am 05.07.2011. Verfasst von Alice Chen. Beteiligte Einrichtung: Division of Cancer Treatment and Diagnosis National Institutes of Health, National Cancer Institute, Rockville, MD 20852, USA. chenali@mail.nih.gov. Hauptthemen laut MEDLINE: Poly(ADP-ribose) Polymerase Inhibitors. Die Arbeit wurde bisher 170-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Cancer Treatment and Diagnosis National Institutes of Health, National Cancer Institute, Rockville, MD 20852, USA. chenali@mail.nih.gov
Zitieren
APA
Chen, A. (2011). PARP inhibitors: its role in treatment of cancer. Chinese Journal of Cancer, 463-471. https://doi.org/10.5732/cjc.011.10111
Vancouver
Chen A. PARP inhibitors: its role in treatment of cancer. Chinese Journal of Cancer. 2011:463-471. doi:10.5732/cjc.011.10111
BibTeX
@article{Chen2011,
author = {Chen, Alice},
title = {PARP inhibitors: its role in treatment of cancer},
journal = {Chinese Journal of Cancer},
year = {2011},
pages = {463--471},
doi = {10.5732/cjc.011.10111}
}
EUVIMED